Erica Dorillo

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

Journal: HemaSphere
Published: August 18, 2025

Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice.

Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice.

Journal: Leukemia
Published: August 22, 2024

Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies.

Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies.

Journal: International journal of molecular sciences
Published: July 17, 2024

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.

Journal: Cancers
Published: May 26, 2023

FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia.

FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia.

Journal: EJHaem
Published: May 19, 2023

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.

Journal: Frontiers in oncology
Published: May 10, 2023

Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.

Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.

Journal: British journal of haematology
Published: September 29, 2022

GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.

GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.

Journal: Cell death & disease
Published: January 17, 2022

Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.

Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.

Journal: Frontiers in oncology
Published: June 22, 2021

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.

Journal: International journal of molecular sciences
Published: May 14, 2021

NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status.

NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status.

Journal: Frontiers in oncology
Published: February 16, 2021

NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models.

NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models.

Journal: Bone marrow transplantation
Published: January 29, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026